259 results on '"Pavlovsky S"'
Search Results
2. Using the requirements of modern standardization in food enterprises
3. P1081: PET-ADAPTED THERAPY AFTER THREE CYCLES OF ABVD FOR ALL STAGES OF HODGKIN LYMPHOMA: LONG TERM FOLLOW UP OF THE GATLA LH-05 TRIAL
4. APPLICATION OF PROCESSING PRODUCTS OF VEGETABLE RAW MATERIAL IN MARSHMALLOW PRODUCTION
5. Autologous Bone Marrow Transplantation Versus Chemotherapy in Acute Myeloblastic Leukemia Patients: Argentinean Study Results
6. Malignant T-Cell and Other Non-Hodgkin’s Lymphomas
7. RATIONAL NUTRITION AS A PART OF RECOVERY MEASURES FOR INCREASED PHYSICAL LOADS
8. PET‐ADAPTED THERAPY AFTER THREE CYCLES OF ABVD FOR ALL STAGES OF HODGKIN LYMPHOMA: LONG TERM FOLLOW UP OF THE GATLA LH‐05 TRIAL
9. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management
10. Is the international staging system superior to the Durie–Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplant
11. Autologous stem cell transplantation in multiple myeloma patients <60 vs ⩾60 years of age
12. Valacyclovir prophylaxis for the prevention of Herpes simplex virus reactivation in recipients of progenitor cells transplantation
13. Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials
14. Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR)
15. To the structure of the spinal cord in sterlets
16. ASSESSMENT OF STALLIONS OF THE NOVOALEKSANDROVSKY DRAFT BREED
17. A randomized study of mitoxantrone plus cytarabine versus daunomycin plus cytarabine in the treatment of previously untreated adult patients with acute nonlymphocytic leukemia
18. Autologous stem cell transplantation in multiple myeloma patients <60 vs ≥60 years of age
19. Autologous Bone Marrow Transplantation Versus Chemotherapy in Acute Myeloblastic Leukemia Patients: Argentinean Study Results
20. IgG1-kappa biclonal gammopathy associated with multiple myeloma suggests a regulatory mechanism
21. Use of GnRH Analogs for Functional Protection of the Ovary and Preservation of Fertility during Cancer Treatment in Adolescents: A Preliminary Report
22. COMPLEX APPROACH TO TREATMENT OF PATIENTS WITH NON-ALCOHOLIC STEATOGEPATITIS COMBINED WITH DIABETES MELLITUS TYPE 2
23. A randomized comparison of two chemotherapy regimes: BACOP vs COPP in the treatment of diffuse histiocytic and mixed lymphoma
24. Randomized study of chemotherapy alone vs. chemotherapy plus radiotherapy in Clinical Stages IA-IIA Hodgkin’s disease
25. International myeloma working group recommendations for the diagnosis and management of myeloma-related renal impairment
26. Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib:A multicenter international myeloma working group study
27. A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia.
28. IgG1-κ biclonal gammopathy associated with multiple myeloma suggests a regulatory mechanism
29. Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib
30. Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
31. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management
32. International Myeloma Working Group. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management
33. The role of vertebral augmentation in multiple myeloma: International Myeloma Working Group Consensus Statement
34. Pediatric Hodgkin Lymphoma through Clinical Trials in Argentina in the Past 46 Years: The GATLA Experience
35. Numerical Analysis of Parameters of the Radiant Heating System with Radiating Panels
36. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management
37. Argentina. Telling the truth to cancer patients in a multicultural society
38. Chemical sensing materials II: Electrically conductive peroxide crosslinked SEBS copolymers systems
39. Chemical sensing materials. I. Electrically conductive SEBS copolymer systems
40. Gammopathy of undetermined significance: Identification of prognostic factors and survival
41. Monitoring response to imatinib by quantitative real-time polymerase chain reaction (RQ-PCR) in chronic phase, chronic myeloid leukemia patients in complete cytogenetic remission
42. Prognostic factors in monoclonal gammopathy of undetermined significance
43. Ceftriaxone plus Once Daily Aminoglycoside with Filgrastim for Treatment of Febrile Neutropenia: Early Hospital Discharge vs. Standard In-Patient Care
44. Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin's disease. International Database on Hodgkin's Disease Overview Study Group.
45. Autologous peripheral blood progenitor cell transplantation mobilized with high-dose cytarabine in acute myeloid leukemia in first complete remission
46. Randomized trial of CVPP for three versus six cycles in favorable-prognosis and CVPP versus AOPE plus radiotherapy in intermediate-prognosis untreated Hodgkin's disease.
47. Argentina.
48. Multivariate analyses of prognostic factors associated with hematopoietic recovery in autograft patients with different sources of progenitor cells
49. Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease.
50. Long-term results of a multicentre randomised, comparative phase III trial of CHOP versus CNOP regimens in patients with intermediate-and high-grade non-Hodgkin's lymphomas
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.